Lack of efficacy of blueberry in nutritional prevention of azoxymethane-initiated cancers of rat small intestine and colon by Simmen, Frank A et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Gastroenterology
Open Access Research article
Lack of efficacy of blueberry in nutritional prevention of 
azoxymethane-initiated cancers of rat small intestine and colon
Frank A Simmen*1,3, Julie A Frank3,5, Xianli Wu1,3, Rijin Xiao1,3,6, 
Leah J Hennings2 and Ronald L Prior3,4
Address: 1Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, 
USA, 2Department of Pathology, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA, 3Arkansas 
Children's Nutrition Center, 15 Children's Way, Little Rock, AR 72205, USA, 4USDA Agricultural Research Service, 15 Children's Way, Little Rock, 
AR 72205, USA, 5Current address : Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, 
USA and 6Current address : Center for Animal Nutrigenomics and Applied Animal Nutrition, Alltech Inc., Nicholasville, KY 40356, USA
Email: Frank A Simmen* - simmenfranka@uams.edu; Julie A Frank - JAFrank@uams.edu; Xianli Wu - WuXianli@uams.edu; 
Rijin Xiao - Rxiao@Alltech.com; Leah J Hennings - Lhennings@uams.edu; Ronald L Prior - RPrior@uams.edu
* Corresponding author    
Abstract
Background:  Blueberries may lower relative risk for cancers of the gastrointestinal tract.
Previous work indicated an inhibitory effect of consumed blueberry (BB) on formation of aberrant
crypt foci (ACF) in colons of male Fisher F344 rats (inbred strain). However, effects of BB on colon
tumors and in both genders are unknown.
Methods: We examined efficacy of BB in inhibition of azoxymethane (AOM)-induced colon ACF
and intestine tumors in male and female Sprague-Dawley rats (outbred strain). Pregnant rats were
fed a diet with or without 10% BB powder; progeny were weaned to the same diet as their dam
and received AOM as young adults.
Results: Male and female rats on control diet had similar numbers of ACF at 6 weeks after AOM
administration. BB increased (P < 0.05) ACF numbers within the distal colon of female but not male
rats. There was a significant (P < 0.05) diet by gender interaction with respect to total colon ACF
number. Colon and duodenum tumor incidences were less in females than males at 17 weeks after
AOM. BB tended (0.1 > P > 0.05) to reduce overall gastrointestinal tract tumor incidence in males,
however, tumor incidence in females was unaffected (P > 0.1) by BB. There was a tendency (0.1 >
P  > 0.05) for fewer adenocarcinomas (relative to total of adenomatous polyps plus
adenocarcinomas) in colons of female than male tumor-bearing rats; in small intestine, this gender
difference was significant (P < 0.05). BB favored (P < 0.05) fewer adenocarcinomas and more
adenomatous polyps (as a proportion of total tumor number) in female rat small intestine.
Conclusion: Results did not indicate robust cancer-preventive effects of BB. Blueberry influenced
ACF occurrence in distal colon and tumor progression in duodenum, in gender-specific fashion.
Data indicate the potential for slowing tumor progression (adenomatous polyp to
adenocarcinoma) by BB.
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Background
Epidemiological findings generally indicate a lowering of
relative risk of colorectal cancers in humans who regularly
consume large amounts of fruits [1-7]. Conversely, indi-
viduals consuming relatively small amounts of fruits may
have increased risk of colon cancer [8]. Fruit consumption
lowers relative risk for cancers of the colon [7,9,10], rec-
tum [11], and small intestine [12]. Protective effects of
fruits may be more robust for cancers of the colon than
rectum [2,10,13], may be stronger in distal than proximal
colon sub-sites [2,13,14], and in at least one study were
more prominent in men than women [10]. Adenomatous
polyps (adenomas), the precursors to colorectal adenocar-
cinomas, are less prevalent in high fruit consumers
[13,15]. In addition, colorectal adenoma growth was
inversely associated with consumption of fruits and ber-
ries [16]. In spite of the above, there are few epidemiolog-
ical studies that have examined for effects of specific types
of fruits and in particular berries on human colorectal
cancer risk.
Berry fruits contain a diverse array of phytochemicals that
may have human health benefits [17]. The possible colon
cancer-preventive actions of berries have received recent
interest [18]. Extracts of berries inhibited, in dose-depend-
ent fashion, proliferation of human cancer cell lines [19].
Among the phenolic compounds of the blueberry (BB),
the anthocyanins were shown to be the most potent
inhibitors of cell proliferation and inducers of apoptosis
when tested, in relatively pure form, on colon cancer cell
lines [20,21]. In humans consuming blueberries, a signif-
icant portion of the ingested anthocyanins reach the colon
[22] where they may contribute to tissue anti-oxidant
capacity and hence, to anti-carcinogenesis. Additionally,
consumption of BB results in postprandial increases in
plasma antioxidant level in humans [23]. Pterostilbene,
another phytochemical constituent of blueberry, impedes
advancement of the cell cycle and induces apoptosis of
human cancer cell lines in vitro [24].
In vivo studies of the colon cancer-preventive actions of
berries have used the AOM-administered male Fisher 344
rat or the Apcmin mutant mouse. Freeze-dried black rasp-
berries in the diet inhibited the size (and therefore devel-
opment) of colon aberrant crypt foci (ACF) as well as
tumor multiplicity in male Fisher 344 rats [25]. In this
same animal model, blueberry suppressed the total
number of colon ACF per rat [26], similar to that observed
with 40 ppm of pterostilbene added to diet [27]. In the
Apcmin mouse model, the blackberry anthocyanin, cyani-
din-3-glucoside, as well as an anthocyanin enriched
extract of bilberry decreased numbers of small intestine
adenomas [28]. Also in Apcmin mice, supplementation of
diet with bilberry, lingonberry or cloudberry led to reduc-
tions in overall number and size of intestinal adenomas
[29]. Feeding tart cherries or anthocyanin extract of cher-
ries to Apcmin mice inhibited the frequency and size of
intestine adenomas [30,31]. Thus, suppressive effects of
berries on small intestine adenomas in Apcmin  mice
appear to be robust and consistent between studies.
Despite the above support for preventive effects of fruits
and berries on colorectal cancers, several caveats remain.
The in vitro studies typically observed effects of anthocy-
anins in the micromolar range, concentrations that may
never be reached systemically or within the lumens of the
small intestine or colon. The Apcmin mouse does not
model sporadic colon cancers, the most frequent type of
colorectal cancer. The AOM-treated, inbred Fisher 344
male rat is highly sensitive to dietary and chemical manip-
ulation of colon carcinogenesis and many structurally
diverse molecules have been shown to inhibit or promote
ACF and/or tumors in this model [32]. Therefore, results
from the above animal models should be examined in
outbred rat strains and in both genders.
Insulin and insulin resistance have been positively linked
with AOM-induced carcinogenesis in rats [33,34]. Serum
C-peptide, a bio-marker of insulin secretion, is positively
associated with colorectal cancer risk in humans [35] and
is regulated by dietary factors [36]; however, relevance of
insulin to suppressive effects of fruit consumption on
colorectal cancer development is unclear. In this study, we
used a validated, AOM-treated Sprague-Dawley (outbred)
rat model (males and females) to evaluate effects of BB on
intestine tumor genesis and serum C-peptide. Results did
not provide strong support for cancer-preventive effects of
BB in the rat colon.
Methods
Materials
Freeze-dried, powdered blueberry ['HiActives' Wild Blue-
berry Powder, Lot #01351573, derived from wild blueber-
ries (Vaccinium angustifolium)] was obtained from
FutureCeuticals Inc. (Momence, IL). Composition of
blueberry (BB) powder was 2.73% protein, 5.5% fiber,
3.08% fat and 2.96% moisture. BB contained over 20
individual anthocyanins; the total amount of anthocy-
anins was ~28 mg/g dry weight. AIN-93G diets were for-
mulated as in Table 1. The 10% BB dose was chosen in
order to maximize consumption of anthocyanins and
without significantly affecting food consumption when
compared to the control diet.
Animals
Animal use protocols were approved by the University of
Arkansas for Medical Sciences Institutional Animal Care
and Use Committee. The experiment was designed to
examine effects of "lifetime" BB diet exposure (including
prenatal and pre- and post-weaning periods) onBMC Gastroenterology 2009, 9:67 http://www.biomedcentral.com/1471-230X/9/67
Page 3 of 9
(page number not for citation purposes)
azoxymethane (AOM)-induced carcinogenesis. This
experimental design is presented in Figure 1. Forty-four
pregnant (gestation day 4) Sprague-Dawley rat dams
(Charles River Laboratories; Wilmington, MA) were
received in the Association for Assessment and Accredita-
tion of Laboratory Animal Care - approved animal facility
at the Arkansas Children's Hospital Research Institute.
Dams were immediately placed on diets [Control (n = 22)
or 10% BB (n = 22)]. At postnatal day (PND) 3, pups were
weighed and litters culled to five males and five females.
Pups were weaned at PND 21 and given the same diet as
their dam for the duration of the experiment. After lacta-
tion, dams were used for studies not described here. Some
offspring (randomly selected) were used for studies of adi-
posity and metabolism that also were outside the purview
of the present focus and hence are not described here. Ani-
mals were housed in polycarbonate cages and permitted
ad libitum access to food and water. Animal rooms were
temperature- and humidity-controlled with a 12-h light-
dark cycle.
Tumors and ACF
AOM (Midwest Research Institute; Kansas City, MO) was
administered subcutaneously (15 mg/kg body weight) to
offspring at PND 53 and again at PND 60. Animals were
weighed weekly throughout the duration of the experi-
ment. ACF are observed in the colon mucosa during
AOM-induced colon tumorigenesis and are used as an
intermediate end point to evaluate cancer-prevention by
nutritional and chemo-preventive factors [32]. Colons
were obtained from 15 randomly selected animals of each
diet group and gender at 6 weeks after the second AOM
administration and used for visualization of ACF. Each
colon was divided into three equal-length segments, des-
ignated as proximal, mid or distal. Segments were stained
with 0.2% methylene blue in PBS for 3-5 minutes, rinsed
with phosphate-buffered saline (PBS) for 1-2 minutes,
and placed in 0.4% formalin-PBS. ACF were visualized
using a Nikon AMZ800 stereoscope (40 × magnification)
by a single observer blinded to treatment. ACF were ele-
vated (single or multiple clustered) crypts with elongated
and enlarged openings. The regional assignment of each
ACF and number of crypts per ACF were recorded [37].
At 16 weeks post-AOM, a group of 10 animals from each
diet group and gender were randomly chosen and sub-
jected to necropsy for confirmation of tumor presence. At
17 weeks post-AOM, the liver, stomach, spleen, small
intestine, cecum, colon and rectum from 73 or 74 animals
of each diet group and gender were obtained and
inspected for presence of tumors. Tumor location was
determined relative to the distal end of the colon or small
intestine. Tumors were removed, weighed, marked on the
Table 1: Experimental AIN-93G diets
Component (g/kg) Control Blueberry (BB)
Casein 200 196.3
L-Cystine 3 3
Corn Starch 397.5 310.3
Maltodextrin 132 132
Sucrose 100 100
Corn Oil 70 69
Cellulose 50 41.9
AIN93G Mineral Mix 35 35
AIN93G Vitamin Mix 10 10
Choline Bitartrate 2.5 2.5
TBHQ 0.014 0.014
Blueberry Powder 0 100
Total 1000 1000
Experimental design Figure 1
Experimental design. Gastrointestinal tissues were collected at 6 and 17 weeks after the second AOM administration for 
determination of ACF and tumors, respectively. PND, postnatal day.BMC Gastroenterology 2009, 9:67 http://www.biomedcentral.com/1471-230X/9/67
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serosal surface with India ink, and placed in formalin.
Serum was prepared from each animal. Pancreas and liver
weights were recorded.
Small intestine and colon tumors were classified as ade-
nomatous polyp (adenomatous polyp or adenomatous
polyp with carcinoma in situ) or adenocarcinoma (inva-
sive adenocarcinoma, invasive mucinous carcinoma, or
metastatic adenocarcinoma with signet ring features) as
described previously [36]. Diagnostic features of adenom-
atous polyps were well differentiated epithelial cells with
low mitotic rate and absence of invasion. Adenocarcino-
mas were poorly differentiated, with cellular and nuclear
pleomorphism, high mitotic rate, and evidence of inva-
sion. Some colons manifested nodules which had a
tumor-like appearance on gross examination, but which
were comprised of focal areas/aggregates of lymphoid B
and T cells [38]. These lesions, as well as the few observed
mammary, liver, spleen, stomach, cecal and rectal tumors
were excluded from statistical analysis.
C-peptide
Serum C-peptide levels were measured using a rat C-pep-
tide radioimmunoassay (Linco Research, Inc, St. Charles,
MO). Sera (100 μl) from n = 12 to 14 animals of each diet
group and each gender at 17 weeks post-AOM were
assayed in duplicate in two replicate assays. Sensitivity of
the assay was 25 pM and the inter-assay variation was less
than 10%.
Statistics
Statistical analysis was performed using SigmaStat for
Windows, version 3.11 (Systat Software, Inc., Richmond,
CA). BB effects on AOM-induced tumor incidence at 17
weeks post-AOM were examined by χ2 analysis. Tumor
pathology was compared for effects of diet and gender
using Fisher's Exact Test. The effects of BB on colon ACF
number and ACF crypt multiplicity (number of crypts per
ACF) were evaluated by Student's t test or the Mann-Whit-
ney rank sum test, the latter when data were not normally
distributed. The interaction between effects of diet and
gender on ACF was determined using two-way ANOVA.
Effects of BB on serum C-peptide concentration were eval-
uated using Student's t test. All values are presented as
means ± S.E.M. Differences between means were consid-
ered to be significant at P < 0.05, whereas 0.1 > P > 0.05
was considered to represent a tendency for a difference.
Results
As expected, female rats gained less weight over time than
did male rats (Figure 2); presumably due to gender differ-
ences in locomotor activity, blood androgen levels, insu-
lin sensitivity and nutrient uptake/utilization, among
other physiological differences. However, inclusion of BB
to the diet had no effect on body weight accretion by rats
of either gender (Figure 2); indicating no effect of BB on
food consumption by either sex. BB had no effect on
lengths of colon or rectum or weights of pancreas or liver
(tissue weights were normalized to body weight) within
each gender at 17 weeks post-AOM (data not shown). BB
also had no effect on serum C-peptide concentration, an
indicator of steady-state insulin secretion; however, C-
peptide levels were ~30% lower for female compared to
male rats (data not shown). Tumor status (presence or
absence of tumors) had no effect on C-peptide concentra-
tion.
At 6 weeks after the second AOM treatment, male and
female rats on the control diet had similar numbers of
ACF (Tables 2, 3). ACF were most prevalent in mid, fol-
lowed by distal colon; while proximal colons had fewer
ACF. Addition of BB to the diet resulted in fewer ACF in
mid and distal colons of male rats; however, results were
not statistically significant (Table 2). Contrary to our
hypothesis, BB consumption led to increased (P < 0.05)
ACF numbers within the distal region of female rat colons
(Table 2). ACF data were grouped by size, summed for
each colon, and analyzed for effects of diet (Table 3).
There was a tendency (0.1 > P > 0.05) for a ~24% reduc-
tion in total number of ACF in the colons of BB-fed male
rats. In female rats, BB tended (0.1 > P > 0.05) to increase
(by ~30%) the number of small ACF (Table 3). A signifi-
cant (P < 0.05) gender by diet interaction was observed for
occurrence of small and small plus large ACF (Table 3). BB
and gender did not affect ACF crypt multiplicity (no.
crypts per ACF) in male or female rat colons (Table 3).
We evaluated tumor parameters at 17 weeks after AOM
treatments, a time-point when tumors are prevalent in
large and small intestines of this animal model (39).
Colon tumor incidence was lower in female compared to
male rats, regardless of diet (Table 4). Tumor incidence in
small intestines (duodenum) also was reduced for female
rats, regardless of diet. Comparing data summed for all
segments of the colon and small intestine, BB tended (0.1
> P > 0.05) to reduce tumor incidence in males (Table 4).
In contrast, tumor incidence in female rat colon and small
intestine was unaffected (P > 0.1) by BB (Table 4).
BB had no effect on tumor multiplicity (# tumors per
tumor-bearing rat) in colon or small intestine and this
measure was also unaffected by gender (Figure 3A, B).
Similarly, no differences in tumor weight were apparent
between diets or gender (data not shown). The ratio of
number of adenocarcinomas to the total number of ade-
nomatous polyps plus adenocarcinomas was determined
as an index of tumor progression. In the colon, there was
a tendency for fewer adenocarcinomas in female than
male rats; in small intestine, the gender difference was sig-
nificant (P < 0.05) (Figure 3C, D). BB diet favored fewerBMC Gastroenterology 2009, 9:67 http://www.biomedcentral.com/1471-230X/9/67
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adenocarcinomas and more adenomas (as a proportion of
total tumor numbers) in female rat small intestine (P <
0.05).
Discussion
Our results did not provide strong support for a beneficial
role of BB in inhibition of AOM-induced intestinal can-
cers in Sprague-Dawley rats. BB only tended to reduce the
total number of colon ACF and overall intestine tumor
incidence and only in males. In female rats, BB aug-
mented ACF numbers in distal colon, contrary to the
hypothesized protective action. The non-significant ten-
dency for a reduced number of ACF in male Sprague-Daw-
ley rats consuming BB diet somewhat agrees with findings
by Boateng et al., 2007 [26], who studied male Fisher 344
rats. However, the latter group reported a statistically sig-
nificant and robust suppression of ACF by BB diet, in con-
trast to that observed here. This difference between studies
may reflect the two rat strains used, the differences in
group size (n = 6 animals for previous study, n = 15 ani-
mals for present study), and/or the differing amounts of
blueberry incorporated in the diet (10% in the present
study, 5% in the previous study). With regard to differ-
ences in dietary content of blueberry, we do not consider
this a likely cause of the study differences, since anthocy-
anins suppressed adenoma formation in a linear dose-
dependent fashion in Apcmin mice [28]. It is plausible that
Sprague-Dawley rats are less susceptible (and/or individu-
ally more variable) to dietary influences on AOM-induced
ACF and tumor formation than inbred Fisher 344 rats,
which also may contribute to differences between studies.
In marked contrast to these findings was the significant
increase in ACF occurrence in distal colon of female rats
consuming BB. The basis for this novel, gender-specific
response to BB is unknown, albeit, we speculate that this
may involve functional interactions of BB constituent(s)
with female sex hormones and/or receptors.
Regional distribution of adenocarcinomas closely fol-
lowed that for ACF, as in our prior studies [36,37,39]. Spe-
Postnatal growth of experimental animals Figure 2
Postnatal growth of experimental animals. Body weights (mean and SEM) are shown. PND, postnatal day.
Table 2: Colon ACF number (per rat) at 6 weeks after second carcinogen treatment.
Male Female
Region Control 10% BB Control 10% BB
Proximal Colon 1.9 ± 0.6 2.2 ± 0.7 2.4 ± 0.8 2.7 ± 0.8
Middle Colon 92.7 ± 12.6 74.3 ± 9.0 77.7 ± 11.8 103.1 ± 9.9
Distal Colon 47.1 ± 5.6 34.7 ± 3.0 42.1 ± 5.4 a 58.1 ± 5.3 b
a, bindicate a significant difference between groups (P < 0.05); n = 15 animals of each gender for each diet group.BMC Gastroenterology 2009, 9:67 http://www.biomedcentral.com/1471-230X/9/67
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cifically, ACF and tumors were more prevalent in mid >
distal > proximal colon. Several epidemiological studies
reported more pronounced cancer-protective effects of
fruits in distal rather than proximal colon of humans
[2,13,14]. The functional correspondence of the mid
colon of the rat to one or more sub-sites of the human
colon is not known; anatomically, it corresponds to trans-
verse and upper distal regions of the human colon. The
lack of inhibitory effect of BB on tumorigenesis in the rat
colon may suggest that BB will not be preventive for
human colon cancers, although epidemiological studies
are necessary to resolve this question.
The similar ACF numbers for male and female rats on con-
trol diet, but less frequently occurring colon tumors in
females relative to males, were noted. Thus, progression of
ACF to adenomatous polyps may be slowed or partially
blocked in female rats or alternatively, ACF in female rats
may regress to a greater extent during the later stages of
tumorigenesis, also leading to fewer polyps. Such mecha-
nisms have a precedent in the case of AOM-treated AKR/J
mice which are resistant to colon tumor-formation but
manifest ACF in their colons [40]. Striking differences in
tumor incidence with gender were maintained across the
three regions of the colon as well as proximal small intes-
tine (duodenum). This is consistent with previous obser-
vations of greater tumor incidence in male than female
rats after administration of colon carcinogens [41-43].
Since ACF numbers were similar for males and female
Sprague-Dawley rats on control diet, liver activation of
AOM to the proximate carcinogen, methylazoxymethanol
Table 3: Colon ACF number and multiplicity at 6 weeks post-
AOM *
Male Female
Number of Small ACF
Control 129.5 ± 15.4 117.6 ± 15.1 a
10% BB 99.9 ± 8.9 152.8 ± 11.9 b
Interaction between diet and gender P = 0.016
Number of Large ACF
Control 12.2 ± 2.4 7.1 ± 2.5
10% BB 8.1 ± 1.7 10.1 ± 2.2
Interaction between diet and gender NS
Total Number of ACF
Control 141.7 ± 16.7 a 124.7 ± 15.2 a
10% BB 107.9 ± 10.0 b 162.8 ± 12.8 b
Interaction between diet and gender P = 0.012
ACF Crypt Multiplicity
Control 2.1 ± 0.1 1.9 ± 0.1
10% BB 2.0 ± 0.1 1.9 ± 0.1
Interaction between diet and gender NS
*Small ACF includes those with 1, 2 or 3 crypts; large ACF are those 
with 4 or more crypts; total ACF = no. small ACF + no. large ACF; 
ACF crypt multiplicity = no. of crypts per ACF.
a, b within a column represents 0.1 > P > 0.05, student's t-test; also 
shown are P values for overall interaction between diet and gender as 
determined by two-way ANOVA.
n = 15 animals per gender for each diet group.
NS: P > 0.1
Table 4: Incidence of AOM-induced tumors at 17 weeks post-AOM *
Male Female









Proximal colon 5.5 (4) 4.1 (3) 1.4 (1) 2.7 (2) NS
Middle colon 31.5 (23) 20.3 (15) 8.1 (6) 10.8 (8) P < 0.001
Distal colon 10.9 (8) 10.8 (8) 0 (0) 2.7 (2) P < 0.01
Entire colon 41.1 (30) 29.7 (22) 9.5 (7) 16.2 (12) P < 0.001
Proximal SI ** 23.3 (17) 12.2 (9) 6.8 (5) 6.8 (5) P < 0.01
Middle SI 1.4 (1) 1.4 (1) 0 (0) 0 (0) NS
Distal SI 0 (0) 0 (0) 0 (0) 0 (0) NS
Entire SI 24.7 (18) 13.5 (10) 6.8 (5) 6.8 (5) P < 0.01
Colon + SI 56.2 (41) a 41.8 (31) b 16.2 (12) 23.0 (17) P < 0.001
* Incidence is percentage of tumor-bearing animals; actual number of animals with each tumor is shown in parentheses; gender effects were 
calculated from combined diet groups; six rectal tumors, two mammary tubular adenomas, one biliary cystadenoma, two cecal tumors, one 
stomach tumor, one spleen tumor, and a number of nodules representing focal areas of lymphoid hyperplasia [38] also were found; all were 
excluded from calculations of small intestine and colon tumor indices.
** SI: small intestine (almost all tumors were found in duodenum; with the exception of two in the jejunum).
a, b indicate a tendency for a difference (P = 0.081); NS: P > 0.1BMC Gastroenterology 2009, 9:67 http://www.biomedcentral.com/1471-230X/9/67
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[44] likely does not differ with gender. Rather, the
involvement of systemic or local factor(s) that affect post-
initiation phases of intestinal tumorigenesis and which
exhibit sexual dimorphism is suggested. We speculate that
insulin may be one such factor, since C-peptide levels
were significantly lower in female rats (presumably as a
consequence of their increased insulin sensitivity) and
insulin (and insulin resistance) have been positively
linked with AOM carcinogenesis in rats [33,34]. Interest-
ingly, incidence of colorectal cancer is slightly lower in
women than men [45]. Thus, a further understanding of
how gender affects tumorigenesis in this animal model
may be relevant to elucidating endocrine and other influ-
ences on human colorectal cancer incidence rates.
Regional differences in tumor incidence within the colon
and small intestine have been reported [36,37,39,46,47]
and were confirmed here. Another laboratory has shown
in male Sprague-Dawley rats that AOM induces DNA
modifications (alkylation) to similar extents in proximal
and distal halves of the colon; however, the distal half of
the colon responds to these DNA modifications with a
greater degree of apoptosis and DNA repair, compared to
proximal colon [46]. In view of the known apoptosis-
inducing effects of anthocyanins and stilbenes in vitro, we
hypothesized that these molecules, when provided via BB
diet, would promote apoptosis of colon epithelial cells
whose DNA was newly modified by AOM during initia-
tion of carcinogenesis, thus resulting in fewer ACF and
Tumor multiplicity and tumor pathology for experimental animals Figure 3
Tumor multiplicity and tumor pathology for experimental animals. The relative proportion of tumor-bearing animals 
having single or multiple (> 1) tumors in the colon (A) or small intestine (B) was determined. Relative proportion of tumors 
classified as adenomatous polyps (AP) or adenocarcinomas (AC, this group also included AC with signet ring features) in colon 
(C) and small intestine (D) is presented as percentage of AP + AC. n = 73 (control male rats) or n = 74 (10% BB male and 
female rats, control female rats). Actual numbers of animals having one or greater than one tumor also is indicated in A and B. 
Actual numbers of AP and AC tumors also are indicated in C and D.BMC Gastroenterology 2009, 9:67 http://www.biomedcentral.com/1471-230X/9/67
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tumors. However, our ACF and tumor results did not sup-
port this hypothesized action. Perhaps, the levels of these
bio-active factors within the microenvironment of the
colonic crypt and luminal epithelium were limiting.
Consumption of fruits may protect against cancer devel-
opment in human small intestine [12]. Indeed, we
observed that BB inhibited the adenoma-adenocarcinoma
transition in female rat duodenum. This is generally con-
cordant with the reported inhibition, by fruit consump-
tion, of colorectal adenoma growth in humans [13,15,16]
and the rather consistent inhibition by berries of ade-
noma growth in Apcmin mice [29-31]. In the latter model,
adenomas are common in small intestine. Thus, collective
findings highlight the potential for use of berries and
fruits in dietary prevention of small intestine tumors.
In vitro and in vivo studies implicate anthocyanins and
other phytochemicals in growth-inhibition of cancerous
cells [20,21,24,27]. Such molecules may have estrogenic
or anti-estrogenic actions [48] which may pertain to the
gender-specificity of effects observed, although this is
speculative. Further studies that examine how BB compo-
nents affect the adenoma-adenocarcinoma transition, and
how this is affected by gender, may yet reveal approaches
for cancer-prevention using whole BB or its constitu-
ent(s), alone or in combination with other colon cancer-
preventive foods or factors.
Conclusion
Results did not demonstrate robust cancer-preventive
effects of BB but identified marked gender differences in
incidence of AOM-induced tumors. Blueberry influenced,
in gender-specific fashion, ACF occurrence in distal colon
and tumor progression in duodenum. These findings
illustrate the complex interplay of bio-active dietary fac-
tors, gender, tissue sub-site, and endocrine status in intes-
tinal carcinogenesis and neoplasia.
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